| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/02/2003 | EP1267917A1 Angiogenic onchocerca volvulus proteins and uses thereof |
| 01/02/2003 | EP1267916A2 Medicament containing a tissue inhibitor of metalloproteinases-2 (timp-2) as an osteo-anabolically active substance |
| 01/02/2003 | EP1267915A2 Methods of treating diseases with activated protein c |
| 01/02/2003 | EP1267914A1 Use of lyosomal acid lipase for treating atherosclerosis and related diseases |
| 01/02/2003 | EP1267913A2 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 01/02/2003 | EP1267912A2 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| 01/02/2003 | EP1267911A1 A method of treatment |
| 01/02/2003 | EP1267910A2 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
| 01/02/2003 | EP1267909A1 Methods of blocking tissue destruction by autoreactive t cells |
| 01/02/2003 | EP1267907A1 Use of mia in immunotherapy |
| 01/02/2003 | EP1267906A1 Lactams as inhibitors of a-beta protein production |
| 01/02/2003 | EP1267904A2 Polypeptoid pulmonary surfactants |
| 01/02/2003 | EP1267903A1 Methods for treating glaucoma |
| 01/02/2003 | EP1267899A2 Salmonella vaccine materials and methods |
| 01/02/2003 | EP1267888A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 01/02/2003 | EP1267881A2 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies |
| 01/02/2003 | EP1267866A2 The treatment of respiratory diseases |
| 01/02/2003 | EP1267851A2 Method and compositions for preventing hormone induced adverse effects |
| 01/02/2003 | EP1267838A1 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 01/02/2003 | EP1267800A1 Methods of modulating hair growth |
| 01/02/2003 | EP1267635A1 Supplementation of equine feedstuffs |
| 01/02/2003 | EP1267616A1 Methods of modulating hair growth |
| 01/02/2003 | EP1238058A4 Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neural cell differentiation |
| 01/02/2003 | EP1169433A4 Human hac3 |
| 01/02/2003 | EP1139755A4 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 01/02/2003 | EP1115886A4 Secreted renilla luciferase |
| 01/02/2003 | EP1105428A4 Novel cleaved fragments of fibrinogen |
| 01/02/2003 | EP1078040A4 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 01/02/2003 | EP1073452B1 Use of deltorphin for treating cytokine mediated hepatic injury |
| 01/02/2003 | EP1061948B1 Sustained-release preparation of physiologically active polypeptide and production thereof |
| 01/02/2003 | EP1053246B1 Beta-sheet mimetics and methods relating to the use thereof |
| 01/02/2003 | EP1030831A4 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| 01/02/2003 | EP1019370B1 Ace-inhibitor nitric salts |
| 01/02/2003 | EP0979284B1 Reagents for vaccination which generate a cd8 t cell immune response |
| 01/02/2003 | EP0948526A4 Contryphan peptides |
| 01/02/2003 | EP0920445B1 Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions |
| 01/02/2003 | EP0885244B1 Peptide immunogens for vaccination against and treatment of allergy |
| 01/02/2003 | EP0854725B1 Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
| 01/02/2003 | EP0806960B1 Extracts of shark cartilage, process of production and uses thereof |
| 01/02/2003 | EP0771216B9 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/02/2003 | EP0745131B1 Targeting gene therapy |
| 01/02/2003 | EP0725081B1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA |
| 01/02/2003 | EP0723440B1 Therapeutic delivery compositions and methods of use thereof |
| 01/02/2003 | EP0662138B1 Long wap promoter for mammary expression of human protein c |
| 01/02/2003 | EP0625988B1 Allosteric modulators of the nmda receptor |
| 01/02/2003 | EP0605428B9 Hormone-secreting pancreatic cells maintained in long-term culture |
| 01/01/2003 | CN1388248A Adenovirus proliferated specifically inside tumor cell to express interferon in high efficiency and its construction method |
| 01/01/2003 | CN1388134A Recombined clathrate protein, its producing process, noble metal-recombined clathrate protein compound, its producing process and recombined DNA |
| 01/01/2003 | CN1388132A Cell death inducing protein and its coding sequence and use |
| 01/01/2003 | CN1388131A Serial medicine carriers, tyrosine hydrozylase fusion protein as new carrier and its prepn |
| 01/01/2003 | CN1387913A Buccal tablet containing SOD |
| 01/01/2003 | CN1387912A Prepn of polygelatine peptide injection |
| 01/01/2003 | CN1097468C Products containing G-CSF and TNF binding protein |
| 01/01/2003 | CN1097467C Vaccine compositions |
| 01/01/2003 | CN1097463C Method for preparing medicinal moxibustion materials extractive preparation for electrical moxibustion therapy |
| 12/31/2002 | USRE37952 Grb3-3 cDNA and polypeptides |
| 12/31/2002 | US6500959 Pyrrolidine derivatives and processes for preparing same |
| 12/31/2002 | US6500945 Nucleotides having chiral phosphorus linkages |
| 12/31/2002 | US6500941 Secreted by human breast cancer mda-mb-175 cells, leads to the formation of a constitutive active receptor complex and stimulates these cells in an autocrine manner |
| 12/31/2002 | US6500940 Apoptotic-associated polypeptide lifeguard (lfg); use to treat disorder associated with increased or decreaase fas-mediated cell death |
| 12/31/2002 | US6500937 Plasmid or vector; sequence encodes mammastatin; useful in the diagnosis and treatment of breast cancer |
| 12/31/2002 | US6500934 Bivalent agonists for G-protein coupled receptors |
| 12/31/2002 | US6500930 Hemoglobin-polysaccharide conjugates |
| 12/31/2002 | US6500929 Protein containing a functional domain of a water-soluble c1 inhibitor and an anchor molecule; suppressing complement activity; membrane bound complement regulatory proteins; transplantation |
| 12/31/2002 | US6500927 For screening for agonists and antagonists of the splice variant receptor activities and to methods of measuring splice variant binding activities |
| 12/31/2002 | US6500924 Package for using antagonists of the vitronectin receptor alpha-v beta3 comprising a metalloproteinase polypeptide of given amino acid sequence; treating arthritis, rheumatoid arthritis, retinopathy and tumors |
| 12/31/2002 | US6500923 Isolated polypeptide that binds to an autoantibody from a dermatomyositis patient to provide means by which dermatomyositis can be detected by way of differential diagnosis |
| 12/31/2002 | US6500920 Inhibitor of transforming growth factor β and A method of inhibiting the biological effects of transforming growth factor |
| 12/31/2002 | US6500918 Conjugate comprising an antinociceptive agent covalently bonded to a blood component |
| 12/31/2002 | US6500843 Inhibitors of rotamase enzyme activity |
| 12/31/2002 | US6500841 Inhibitors of farnesyl-protein transferase |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/31/2002 | US6500809 Neural tissue edema is treated by circulating a hyperoncotic artificial cerebrospinal fluid in the cerebrospinal fluid pathway in the vicinity of edematous tissue to cause the edematous tissue to be dehydrated due to an oncotic gradient |
| 12/31/2002 | US6500807 Gene therapy |
| 12/31/2002 | US6500804 Administering a dipeptidyl aminopeptidase effector which is selected from the group consisting of n-(n-substituted glycyl)2-cyanopyrrolidones, n-aminoacyl thiazolidines, n-aminoacyl pyrrolidines |
| 12/31/2002 | US6500803 Factor VIIa inhibitors |
| 12/31/2002 | US6500802 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
| 12/31/2002 | US6500801 Treatment for Dutch elm disease |
| 12/31/2002 | US6500799 Activating textile carrier to form aldehyde groups, impregnating active carrier in solution bioactive enzyme and drying |
| 12/31/2002 | US6500798 Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators |
| 12/31/2002 | US6500672 A competitive assay for binding activity to recombinant hepatocyte nuclear factor-4 receptors, a chimeric receptor comprising the ligand binding domain of a hnf-4 receptor and dna binding domain of another receptor |
| 12/31/2002 | US6500663 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 12/31/2002 | US6500657 33167, a novel human hydrolase and uses therefor |
| 12/31/2002 | US6500655 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/31/2002 | US6500654 Cardiac-related ankyrin-repeat protein kinase |
| 12/31/2002 | US6500652 Use of nucleic acid molecules as antiviral agents |
| 12/31/2002 | US6500646 Drugs in which peptides having affinity specific for phospholipids, preferably those which are contained in the constituents of lipid bilayers forming the surface layers of cells and of which the proportion in the outer part of each |
| 12/31/2002 | US6500642 Mammalian cdna which encodes a mammalian mapop-3. it also provides for the use of the cdna, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of breast |
| 12/31/2002 | US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 12/31/2002 | US6500640 Nucleic acid molecules encoding modified dorsal tissue affecting factor |
| 12/31/2002 | US6500635 Insulin-like growth factor binding protein (IGFBF-5) |
| 12/31/2002 | US6500613 Isolated pneumococcal surface protein c, pspc, of strepto-coccus pneumoniae having alpha-helical, proline rich and repeat regions |
| 12/31/2002 | US6500470 Use of at least one protein extract of the moringa genus plant seeds and corresponding cosmetic and/or pharmacological composition |
| 12/31/2002 | US6500463 Mixing plasticizable matrix material, liquid plasticizer, encapsulant, non-plasticizable non-gelatinized starch, and component for controlling rate of release of encapsulant under low shear and low temperature, forming into pieces, drying |
| 12/31/2002 | US6500448 Composition comprising biocompatible polymer matrix having particles of metal cation-complexed human growth hormone dispersed therein, and aqueous injection vehicle comprising low viscosity sodium carboxymethyl cellulose |
| 12/31/2002 | US6500437 Fusion protein comprising specified amino acid sequence |
| 12/31/2002 | US6500436 Administering botulinium toxin component coupled to substance p |
| 12/31/2002 | US6500431 Inhibitors of angiogenesis and tumor growth |
| 12/31/2002 | US6500429 Polypeptide analog of a cationic polypeptide such as neurotrophic factor-3 (nt-3) having a different amino acid sequence so that the isoelectric point is lower and the in vivo circulating life and/or absorption is increased |
| 12/31/2002 | US6500428 Antibodies to a lymphocyte surface receptor that binds CAML and methods of use thereof |